Patents by Inventor Mylvaganam Jeyakumar

Mylvaganam Jeyakumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Deriving brown adipose tissue cells
    Patent number: 10017740
    Abstract: The present invention relates to brown adipose tissue (BAT) cells derived from adult stern or progenitor cells, derived from adult white fat tissue (WAT), as well as to methods for deriving such cells.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: July 10, 2018
    Assignee: Plasticell Limited
    Inventors: Marina Tarunina, Yen Choo, Mylvaganam Jeyakumar, Thomas Watson, Meritxell Rosell, Lilian Hook, Diana Hernandez
  • Vessel for culturing cells
    Patent number: 9017998
    Abstract: The present invention provides an apparatus for culturing cells which may comprise two or more culture compartments and a pooling compartment, wherein each of said two or more culture compartments may be separated from the other culture compartments; each of said two or more culture compartments which may comprise a port for the addition or removal of medium; and the pooling compartment communicates with said two or more culture compartments. The present invention also relates to a stand for apparatus for culturing cells.
    Type: Grant
    Filed: February 13, 2012
    Date of Patent: April 28, 2015
    Assignee: Plasticell Ltd.
    Inventors: Marina Tarunina, Yen Choo, Mylvaganam Jeyakumar, Martin Arthur Town, Diana Hernandez-Jaramillo, Christopher James Johnson
  • VESSEL FOR CULTURING CELLS
    Publication number: 20120208273
    Abstract: The present invention provides an apparatus for culturing cells which may comprise two or more culture compartments and a pooling compartment, wherein each of said two or more culture compartments may be separated from the other culture compartments; each of said two or more culture compartments which may comprise a port for the addition or removal of medium; and the pooling compartment communicates with said two or more culture compartments. The present invention also relates to a stand for apparatus for culturing cells.
    Type: Application
    Filed: February 13, 2012
    Publication date: August 16, 2012
    Inventors: Marina Tarunina, Yen Choo, Mylvaganam Jeyakumar, Martin Arthur Town, Diana Hernandez-Jaramillo, Christopher James Johnson
  • Therapeutic compositions and methods of treating glycolipid storage related disorders
    Patent number: 7348000
    Abstract: A method for treating a glycolipid storage-related disorder, comprising administering a therapeutically effective amount of an inhibitor of glycolipid synthesis in combination with an agent capable of increasing the rate of glycolipid degradation or in combination with bone marrow transplantation. Inhibitors of glycolipid synthesis include N-butyldeoxynojirimycin (NB-DNJ), N-butyldeoxygalactonojirimycin (NB-DGJ) or N-nonyldeoxynojirimycin (NN-DNJ). Glycolipid storage-related disorders include Gaucher disease, Sandhoff's disease, Fabry's disease, Tay-Sach's disease, Niemann-Pick C storage disease, GM1 gangliosidosis, genetic disorders in which neuronal glycolipid accumulation contributes to disease pathology.
    Type: Grant
    Filed: January 15, 2004
    Date of Patent: March 25, 2008
    Assignee: Actelion Pharmaceuticals Ltd
    Inventors: Raymond A. Dwek, Terence D. Butters, Mylvaganam Jeyakumar, Frances Mary Platt, David Priestman
  • Therapeutic compositions and methods of treating glycolipid storage related disorders
    Publication number: 20050075305
    Abstract: A method for treating a glycolipid storage-related disorder, comprising administering a therapeutically effective amount of an inhibitor of glycolipid synthesis in combination with an agent capable of increasing the rate of glycolipid degradation or in combination with bone marrow transplantation. Inhibitors of glycolipid synthesis include N-butyldeoxynojirimycin (NB-DNJ), N-butyldeoxygalactonojirimycin (NB-DGJ) or N-nonyldeoxynojirimycin (NN-DNJ). Glycolipid storage-related disorders include Gaucher disease, Sandhoff's disease, Fabry's disease, Tay-Sach's disease, Niemann-Pick C storage disease, GM1 gangliosidosis, genetic disorders in which neuronal glycolipid accumulation contributes to disease pathology.
    Type: Application
    Filed: January 15, 2004
    Publication date: April 7, 2005
    Inventors: Raymond Dwek, Terence Butters, Mylvaganam Jeyakumar, Frances Platt, David Priestman
  • Reversible infertility in male mice following oral administration of alkylated imino sugars: a non-hormonal approach to male contraception
    Publication number: 20040019082
    Abstract: The present invention provides a method by which to reversibly render male mammals infertile. Thus, the disclosed N-substituted imino compounds, and pharmaceutical compositions thereof, completely impair the fertility of male mammals, but exhibit no effect on that of female mammals, and are thus useful as male contraceptives.
    Type: Application
    Filed: March 13, 2003
    Publication date: January 29, 2004
    Applicant: United Therapeutics Corporation
    Inventors: Aarnoud C. van der Spoel, Mylvaganam Jeyakumar, Terry D. Butters, Raymond A. Dwek, Frances M. Platt
  • Culture vessel
    Patent number: D686337
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: July 16, 2013
    Assignee: Plasticell Limited
    Inventors: Marina Tarunina, Yen Choo, Mylvaganam Jeyakumar, Martin Arthur Town, Diana Hernandez-Jaramillo, Christopher James Johnson